425 related articles for article (PubMed ID: 29696624)
21. Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma.
Miselis NR; Wu ZJ; Van Rooijen N; Kane AB
Mol Cancer Ther; 2008 Apr; 7(4):788-99. PubMed ID: 18375821
[TBL] [Abstract][Full Text] [Related]
22. The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2
Harney AS; Karagiannis GS; Pignatelli J; Smith BD; Kadioglu E; Wise SC; Hood MM; Kaufman MD; Leary CB; Lu WP; Al-Ani G; Chen X; Entenberg D; Oktay MH; Wang Y; Chun L; De Palma M; Jones JG; Flynn DL; Condeelis JS
Mol Cancer Ther; 2017 Nov; 16(11):2486-2501. PubMed ID: 28838996
[TBL] [Abstract][Full Text] [Related]
23. Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis.
Egidi MJ; Krug S; Haybaeck J; Michl P; Griesmann H
Br J Cancer; 2023 Oct; 129(8):1225-1237. PubMed ID: 37620408
[TBL] [Abstract][Full Text] [Related]
24. Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression.
Rauca VF; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Mot AC; Rakosy-Tican E; Sesarman A; Banciu M
Sci Rep; 2021 Nov; 11(1):22102. PubMed ID: 34764332
[TBL] [Abstract][Full Text] [Related]
25. Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development.
Pyonteck SM; Gadea BB; Wang HW; Gocheva V; Hunter KE; Tang LH; Joyce JA
Oncogene; 2012 Mar; 31(11):1459-67. PubMed ID: 21822305
[TBL] [Abstract][Full Text] [Related]
26. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic neuroendocrine tumors: targeting the molecular basis of disease.
Khagi S; Saif MW
Curr Opin Oncol; 2015 Jan; 27(1):38-43. PubMed ID: 25390554
[TBL] [Abstract][Full Text] [Related]
28. Relevance of angiogenesis in neuroendocrine tumors.
Teulé A; Casanovas O
Target Oncol; 2012 Jun; 7(2):93-8. PubMed ID: 22592949
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours.
Balan M; Trusohamn M; Ning FC; Jacob S; Pietras K; Eriksson U; Berggren PO; Nyqvist D
Sci Rep; 2019 Oct; 9(1):14636. PubMed ID: 31601958
[TBL] [Abstract][Full Text] [Related]
30. Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression.
Wang L; Li YS; Yu LG; Zhang XK; Zhao L; Gong FL; Yang XX; Guo XL
Biochem Pharmacol; 2020 Aug; 178():114113. PubMed ID: 32579956
[TBL] [Abstract][Full Text] [Related]
31. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.
Banciu M; Metselaar JM; Schiffelers RM; Storm G
Neoplasia; 2008 Feb; 10(2):108-17. PubMed ID: 18283332
[TBL] [Abstract][Full Text] [Related]
32. Apatinib inhibits tumor growth and angiogenesis in PNET models.
Wu S; Zhou J; Guo J; Hua Z; Li J; Wang Z
Endocr Connect; 2019 Jan; 8(1):8-19. PubMed ID: 30557852
[TBL] [Abstract][Full Text] [Related]
33. Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer.
Loi M; Salvatore G; Sottili M; Calosi L; Desideri I; Becherini C; Salvestrini V; Ciccone LP; Stocchi G; Meattini I; Francolini G; Mangoni M; Livi L
Clin Transl Oncol; 2022 Jul; 24(7):1395-1402. PubMed ID: 35212924
[TBL] [Abstract][Full Text] [Related]
34. Investigation into the role of tumor-associated macrophages in the antitumor activity of Doxil.
Banciu M; Schiffelers RM; Storm G
Pharm Res; 2008 Aug; 25(8):1948-55. PubMed ID: 18523874
[TBL] [Abstract][Full Text] [Related]
35. Rejection of intradermally injected syngeneic tumor cells from mice by specific elimination of tumor-associated macrophages with liposome-encapsulated dichloromethylene diphosphonate, followed by induction of CD11b(+)/CCR3(-)/Gr-1(-) cells cytotoxic against the tumor cells.
Takahashi T; Ibata M; Yu Z; Shikama Y; Endo Y; Miyauchi Y; Nakamura M; Tashiro-Yamaji J; Miura-Takeda S; Shimizu T; Okada M; Ueda K; Kubota T; Yoshida R
Cancer Immunol Immunother; 2009 Dec; 58(12):2011-23. PubMed ID: 19365632
[TBL] [Abstract][Full Text] [Related]
36. MK2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Mediated by Macrophages and Metabolomic Factors.
Jacenik D; Lebish EJ; Beswick EJ
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362348
[TBL] [Abstract][Full Text] [Related]
37. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.
Scott AT; Weitz M; Breheny PJ; Ear PH; Darbro B; Brown BJ; Braun TA; Li G; Umesalma S; Kaemmer CA; Maharjan CK; Quelle DE; Bellizzi AM; Chandrasekharan C; Dillon JS; O'Dorisio TM; Howe JR
Clin Cancer Res; 2020 Apr; 26(8):2011-2021. PubMed ID: 31937620
[TBL] [Abstract][Full Text] [Related]
38. Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models.
Singh M; Couto SS; Forrest WF; Lima A; Cheng JH; Molina R; Long JE; Hamilton P; McNutt A; Kasman I; Nannini MA; Reslan HB; Cao TC; Ho CC; Barck KH; Carano RA; Foreman O; Eastham-Anderson J; Jubb AM; Ferrara N; Johnson L
J Pathol; 2012 Aug; 227(4):417-30. PubMed ID: 22611036
[TBL] [Abstract][Full Text] [Related]
39. Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model.
Soltau J; Zirrgiebel U; Esser N; Schächtele C; Totzke F; Unger C; Merfort I; Drevs J
Anticancer Res; 2008; 28(2A):933-41. PubMed ID: 18507039
[TBL] [Abstract][Full Text] [Related]
40. Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors.
Lee L; Ito T; Igarashi H; Miki M; Fujimori N; Kawabe K; Jensen RT; Ogawa Y
Cancer Chemother Pharmacol; 2018 Jan; 81(1):163-169. PubMed ID: 29164297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
